ACTRN12605000076673
Terminated
Phase 3
A randomised phase III study to evaluate the effectiveness prednisolone therapy for late stage Duchenne muscular dystrophy in maintaining lung function
The Children's Hospital at Westmead0 sites40 target enrollmentAugust 5, 2005
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Duchenne muscular dystrophy
- Sponsor
- The Children's Hospital at Westmead
- Enrollment
- 40
- Status
- Terminated
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Duchenne muscular dystrophy, non\-ambulant.
Exclusion Criteria
- •No exclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Activity, Diet and Blood Pressure TrialHypertensionCardiovascular - HypertensionACTRN12605000090617one200
Not yet recruiting
Phase 1
A randomised phase III study to evaluate the effects of methotrexate in the treatment of women with an ectopic pregnancy to prevent the need for surgical intervention.Ectopic pregnancyReproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12607000113459Associate Professor George Condous400
Completed
Not Applicable
The ENERGII Trialower limb fragility fractureLower limb fragility fractureOther - FracturesACTRN12605000252617Professor Maria Crotty200
Completed
Phase 3
Stroke Attention Rehabilitation Trial (START): Impact of Attention Process Training (APT) on Attention and Quality of LifeStrokeStroke -Stroke - IschaemicACTRN12607000045415Clinical Trials research Unit, faculty of Medical and Health Sciences, University of Auckland78
Completed
Phase 2
The DRIP TrialPhlebitis and other adverse outcomes of peripheral venous cannulation.Inflammatory and Immune System - Rheumatoid arthritisACTRN12605000147684Joan Webster754